![Poorya Hosseini](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Poorya Hosseini
Analyste en capital-investissement chez Flagship Pioneering
Postes actifs de Poorya Hosseini
Sociétés | Poste | Début | Fin |
---|---|---|---|
Flagship Pioneering
![]() Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Analyste en capital-investissement | - | - |
Camford Capital
![]() Camford Capital Investment ManagersFinance Camford Capital is a venture capital firm founded in 2013. The firm is headquartered in Palo Alto, California. | Private Equity Investor | 01/03/2021 | - |
Danhua Capital Management LLC
![]() Danhua Capital Management LLC Investment ManagersFinance Danhua Capital Management LLC (Danhua Capital Management) is a venture capital firm founded in 2013 by Andrew Gu. The firm is headquartered in Palo Alto, California. | Private Equity Investor | - | - |
Historique de carrière de Poorya Hosseini
Anciens postes connus de Poorya Hosseini
Sociétés | Poste | Début | Fin |
---|---|---|---|
Generate Biomedicines, Inc.
![]() Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | Fondateur | 01/10/2018 | 28/02/2021 |
Cellarity Inc.
![]() Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Fondateur | 01/11/2017 | 28/02/2021 |
Formation de Poorya Hosseini
McGill University | Graduate Degree |
Massachusetts Institute of Technology | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Canada | 2 |
Opérationnelle
Private Equity Investor | 2 |
Founder | 2 |
Private Equity Analyst | 1 |
Sectorielle
Finance | 5 |
Health Technology | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 5 |
---|---|
Flagship Pioneering
![]() Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Camford Capital
![]() Camford Capital Investment ManagersFinance Camford Capital is a venture capital firm founded in 2013. The firm is headquartered in Palo Alto, California. | Finance |
Generate Biomedicines, Inc.
![]() Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | Health Technology |
Cellarity Inc.
![]() Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Health Technology |
Danhua Capital Management LLC
![]() Danhua Capital Management LLC Investment ManagersFinance Danhua Capital Management LLC (Danhua Capital Management) is a venture capital firm founded in 2013 by Andrew Gu. The firm is headquartered in Palo Alto, California. | Finance |
- Bourse
- Insiders
- Poorya Hosseini
- Expérience